Table 1. Endothelial cells analyzed in the study.
Endothelial cells | Disease | Phase | Age | Gender |
---|---|---|---|---|
MMEC1 | MM | Active | 55 | Male |
MMEC2 | MM | Active | 63 | Female |
MMEC3 | MM | Active | 70 | Male |
MMEC4 | MM | Active | 67 | Female |
MMEC5 | MM | Active | 73 | Female |
MMEC6 | MM | Active | 55 | Male |
MMEC7 | MM | Active | 65 | Male |
MMEC8 | MM | Active | 60 | Female |
MMEC9 | MM | Active | 63 | Female |
cr-MMEC | MM | Complete remission | 71 | Male |
MGEC1 | MGUS | 47 | Male | |
MGEC2 | MGUS | 59 | Male | |
MGEC3 | MGUS | 61 | Female | |
MGEC4 | MGUS | 75 | Female | |
MGEC5 | MGUS | 53 | Male | |
MGEC6 | MGUS | 75 | Male | |
MGEC7 | MGUS | 64 | Male | |
IDAEC | IDA | 56 | Female |
The endothelial cells analyzed in this study were derived from bone marrow aspirates of patients with Multiple Myeloma in active phase (MMEC1-9) or complete remission (cr-MMEC), patients with monoclonal gammopathy of undetermined significance (MGEC1-7) and a patient with anemia due to iron deficiency (IDAEC).